Literature DB >> 10936471

Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study.

B F Culleton1, M G Larson, P S Parfrey, W B Kannel, D Levy.   

Abstract

BACKGROUND: The prognostic significance of proteinuria in older people is not well defined. We examined the associations between proteinuria and incident coronary heart disease, cardiovascular mortality, and all-cause mortality in older people. SUBJECTS AND METHODS: Casual dipstick proteinuria was determined in 1,045 men (mean [+/- SD] age 68 +/- 7 years) and 1,541 women (mean age 69 +/- 7 years) attending the 15th biennial examination of the Framingham Heart Study. Participants were divided by grade of proteinuria: none (85.3%), trace (10.2%), and greater-than-trace (4.5%). Cox proportional hazards analyses were used to determine the relations of baseline proteinuria to the specified outcomes, adjusting for other risk factors, including serum creatinine level.
RESULTS: During 17 years of follow-up, there were 455 coronary heart disease events, 412 cardiovascular disease deaths, and 1,214 deaths. In men, baseline proteinuria was associated with all-cause mortality (hazards ratio [HR] = 1.3, 95% confidence interval [CI] 1.0 to 1.7 for trace proteinuria; HR = 1.3, 95% CI 1.0 to 1.8 for greater-than-trace proteinuria; P for trend = 0.02). In women, trace proteinuria was associated with cardiovascular disease death (HR = 1. 6, 95% CI 1.1 to 2.4), and all-cause mortality (HR = 1.4, 95% CI 1.1 to 1.7).
CONCLUSION: Proteinuria is a significant, although relatively weak, risk factor for all-cause mortality in men and women, and for cardiovascular disease mortality in women.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936471     DOI: 10.1016/s0002-9343(00)00444-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  41 in total

1.  A risk score for chronic kidney disease in the general population.

Authors:  Conall M O'Seaghdha; Asya Lyass; Joseph M Massaro; James B Meigs; Josef Coresh; Ralph B D'Agostino; Brad C Astor; Caroline S Fox
Journal:  Am J Med       Date:  2012-03       Impact factor: 4.965

2.  Proteinuria in midlife and 39-year total mortality: the Honolulu Heart Program.

Authors:  Gotaro Kojima; Kei Sonoda; Christina L Bell; Randi Chen; Helen Petrovitch; Robert D Abbott; George Webster Ross; Suryadutt Venkat; Kamal Masaki
Journal:  Ann Epidemiol       Date:  2014-02-15       Impact factor: 3.797

3.  Proteinuria and rate of change in kidney function in a community-based population.

Authors:  Tanvir Chowdhury Turin; Matthew James; Pietro Ravani; Marcello Tonelli; Braden J Manns; Robert Quinn; Min Jun; Scott Klarenbach; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

Review 4.  Stop chronic kidney disease progression: Time is approaching.

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-05-06

5.  Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study.

Authors:  Yit-Sheung Yap; Wen-Che Chi; Cheng-Hao Lin; Yi-Wen Wu; Yi-Chun Liu
Journal:  Int Urol Nephrol       Date:  2012-03-31       Impact factor: 2.370

Review 6.  [Hypertension and the kidney].

Authors:  Katharina Hohenstein; Bruno Watschinger
Journal:  Wien Med Wochenschr       Date:  2008

Review 7.  Cardiovascular implications of proteinuria: an indicator of chronic kidney disease.

Authors:  Varun Agrawal; Victor Marinescu; Mohit Agarwal; Peter A McCullough
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

8.  Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus.

Authors:  Yit-Sheung Yap; Hung-Yi Chuang; Wen-Che Chi; Cheng-Hao Lin; Yi-Wen Wu; Pai-Chun Chang; Yi-Chun Liu
Journal:  Int Urol Nephrol       Date:  2013-01-26       Impact factor: 2.370

9.  Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Martin G Larson; Judith H Lichtman; Nisha I Parikh; Ramachandran S Vasan; Daniel Levy; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2008-04-28       Impact factor: 8.860

Review 10.  Cardiovascular implications of chronic kidney disease in older adults.

Authors:  Ramnath Dukkipati; Sharon Adler; Rajnish Mehrotra
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.